Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-24T20:30:21.344Z Has data issue: false hasContentIssue false
  • English
  • Français

Does Nasal Colonization or Mupirocin Treatment Affect Recurrence of Methicillin-Resistant Staphylococcus aureus Skin and Skin Structure Infections?

Published online by Cambridge University Press:  02 January 2015

Joseph Rahimian ,
Raymond Khan  and
Keith A. LaScalea
Joseph Rahimian
Affiliation:
Department of Infectious Diseases, St. Vincent's Hospital, Manhattan, New York Medical College, New York, New York
Raymond Khan
Affiliation:
Department of Medicine, St. Vincent's Hospital, Manhattan, New York Medical College, New York, New York
Keith A. LaScalea*
Affiliation:
Department of Medicine, Weill Cornell Medical College, New York, New York
*
Weill Cornell Medical College, 201 East 80th Street, New York, NY 10075 (kal9006@med.cornell.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

Some patients with community-associated methicillin-resistant Staphylococcus aureus skin and skin structure infections have experienced frequent recurrences. We performed a retrospective study and determined that the presence of nasal colonization did not affect recurrence and nasal mupirocin treatment marginally decreased recurrence

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 12 , December 2007 , pp. 1415 - 1416
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Eady, EA, Cove, JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus—an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003;16:103–124.CrossRefGoogle ScholarPubMed
2.Frazee, BW, Lynn, J, Charlesbois, ED, Labert, L, Lowery, D, Perdreau-Remington, F. High Prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005;45:311–320.Google Scholar
3.Fridkin, SK, Hageman, JC, Morrison, M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352 1436–1444CrossRefGoogle ScholarPubMed
4.Shastry, L, Rahimian, J, Lascher, S. Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections in men who have sex with men in New York city. Arch Intern Med 2007;167:854–857.Google Scholar
5.Rohr, U, Mueller, C, Wilhelm, M, Muhr, G, Gatermann, S. Methicillin-resistant Staphylococcus aureus whole body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride. J Hosp Infect 2003;54 305–309.CrossRefGoogle ScholarPubMed
6.Laupland, K, Conly, J. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal Mupirocin: an evidence-based review. Clin Infect Dis 2003;37:933–938.Google Scholar
7.Mody, L, Kauffman, C, McNeil, S, Galecki, A, Bradley, S. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003;37:1467–1474.CrossRefGoogle ScholarPubMed